Back to Journals » HIV/AIDS - Research and Palliative Care » Volume 13

Dual Contraceptive Use and Associated Factors Among Reproductive Age Group on Antiretroviral Therapy in Borena District, Northeast Ethiopia: A Cross-Sectional Study

Authors Amare G, Cherie N, Mekonen AM

Received 28 October 2020

Accepted for publication 30 December 2020

Published 26 January 2021 Volume 2021:13 Pages 107—114

DOI https://doi.org/10.2147/HIV.S289045

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Bassel Sawaya


Gashaw Amare,1 Niguss Cherie,1 Asnakew Molla Mekonen2

1Department of Reproductive Health and Family Health, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Amhara, Ethiopia; 2Department of Health Systems Management, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Amhara, Ethiopia

Correspondence: Asnakew Molla Mekonen
Wollo University, Dessie, Ethiopia
Tel +251921529181
Email amdessie2007@gmail.com

Background: Dual contraceptive method use is defined as the use of any modern contraceptive method with a condom for the reduction of mother-to-child transmission of HIV and sexually transmitted infections between sexual partners. The goal of this study was to assess the proportion and factors associated with dual contraceptive use among reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia.
Objective: To assess the proportion of dual contraceptive use and associated factors among the reproductive age women on antiretroviral therapy in Borena district, Northeast Ethiopia.
Methods: An institutional-based cross-sectional study was conducted among HIV positive reproductive age group women on antiretroviral therapy in Borena district from February 1 to March 1, 2020. A systematic random sampling technique was used to include 417 study participants. A structured interviewer-administered questionnaire was used to collect the data. A binary logistic regression model was used to identify the factors associated with dual contraceptive use. Odds ratio with 95% confidence interval (CI) and P-value were calculated to assess the strength of association.
Results: The results showed that 19.4% of the HIV positive reproductive age group on antiretroviral therapy were using dual contraceptive method. Urban area (AOR=3.66, 95% CI=1.66– 8.09), educated to secondary education and above (AOR=3.54, 95% CI=1.29– 9.76), those who have no desire to have a child (AOR=4.41, 95% CI=2.66– 7.59), those with partners whose HIV status was negative (AOR=4.96, 95% CI=2.66– 12.02) and those with partners whose HIV status was positive (AOR=2.45, 95% CI=1.25– 4.81) were more likely to use the dual contraception method.
Conclusion: This study showed that the proportion of dual contraceptive use was found to be low in accordance with the WHO recommendation. Therefore increased awareness on the advantages of dual contraception and knowing partner’s HIV status is important.

Keywords: dual contraceptive use, antiretroviral therapy, Borena district, Ethiopia

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]